Hianara Aracelly Bustamante

Dr. Hianara Aracelly Bustamante

Instituto de Microbiología Clínica, Universidad Austral de Chile, Valdivia, Los Ríos, Chile
orcid
Assistant Professor (Category III)

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
NANicolas Albornoz
Nicolas Albornoz
Hianara Aracelly BustamanteHianara Aracelly Bustamante
Hianara Aracelly Bustamante
ASAndrea Soza
Andrea Soza
Patricia BurgosPatricia Burgos
Patricia Burgos
Proteasome inhibitors have been actively tested as potential anticancer drugs and in the treatment of inflammatory and autoimmune diseases. Unfortunately, cells adapt to survive in the presence of proteasome inhibitors activating a variety of cell responses that explain why these therapies have not fulfilled their expected results. In addition, all proteasome inhibitors tested and approved by the FDA have caused a variety of side effects in humans. Here, we describe the different types of proteasome complexes found within cells and the variety of regulators proteins that can modulate their activities, including those that are upregulated in the context of inflammatory processes. We also summarize the adaptive cellular responses activated during proteasome inhibition with special emphasis on the activation of the Autophagic-Lysosomal Pathway (ALP), proteaphagy, p62/SQSTM1 enriched-inclusion bodies, and proteasome biogenesis dependent on Nrf1 and Nrf2 transcription factors. Moreover, we discuss the role of IRE1 and PERK sensors in ALP activation during ER stress and the involvement of two deubiquitinases, Rpn11 and USP14, in these processes. Finally, we discuss the aspects that should be currently considered in the development of novel strategies that use proteasome activity as a therapeutic target for the treatment of human diseases.

12 October 2022 in Cellular Signalling
Verified
Journal Article
Closed access
Hianara Aracelly BustamanteHianara Aracelly Bustamante
Hianara Aracelly Bustamante
NANicolás Albornoz
Nicolás Albornoz
EMEugenia Morselli
Eugenia Morselli
ASAndrea Soza
Andrea Soza
Patricia BurgosPatricia Burgos
Patricia Burgos

23 March 2020 in Cells
Verified
Journal Article
Open access
PDF file
Hianara Aracelly BustamanteHianara Aracelly Bustamante
Hianara Aracelly Bustamante
KCKarina Cereceda
Karina Cereceda
AGAlexis Gonzalez
Alexis Gonzalez
GNGuillermo Eduardo Valenzuela Nieto
Guillermo Eduardo Valenzuela Nieto
YCYorka Cheuquemilla
Yorka Cheuquemilla
Patricia BurgosPatricia Burgos
Patricia Burgos
Ubiquitination regulates several biological processes, however the role of specific members of the ubiquitinome on intracellular membrane trafficking is not yet fully understood. Here, we search for ubiquitin-related genes implicated in protein membrane trafficking performing a High-Content siRNA Screening including 1187 genes of the human “ubiquitinome” using amyloid precursor protein (APP) as a reporter. We identified the deubiquitinating enzyme PSMD14, a subunit of the 19S regulatory particle of the proteasome, specific for K63-Ub chains in cells, as a novel regulator of Golgi-to-endoplasmic reticulum (ER) retrograde transport. Silencing or pharmacological inhibition of PSMD14 with Capzimin (CZM) caused a robust increase in APP levels at the Golgi apparatus and the swelling of this organelle. We showed that this phenotype is the result of rapid inhibition of Golgi-to-ER retrograde transport, a pathway implicated in the early steps of the autophagosomal formation. Indeed, we observed that inhibition of PSMD14 with CZM acts as a potent blocker of macroautophagy by a mechanism related to the retention of Atg9A and Rab1A at the Golgi apparatus. As pharmacological inhibition of the proteolytic core of the 20S proteasome did not recapitulate these effects, we concluded that PSMD14, and the K63-Ub chains, act as a crucial regulatory factor for macroautophagy by controlling Golgi-to-ER retrograde transport.

26 July 2024 in Cells
Verified
Journal Article
Open access
PDF file
CBCamila Nicole Pino Belmar
Camila Nicole Pino Belmar
RARayén Aguilar
Rayén Aguilar
GNGuillermo Eduardo Valenzuela Nieto
Guillermo Eduardo Valenzuela Nieto
VRViviana A. Cavieres Risco
Viviana A. Cavieres Risco
CTCristóbal Cerda Troncoso
Cristóbal Cerda Troncoso
Hianara Aracelly BustamanteHianara Aracelly Bustamante
Hianara Aracelly Bustamante
Autophagy engulfs cellular components in double-membrane-bound autophagosomes for clearance and recycling after fusion with lysosomes. Thus, autophagy is a key process for maintaining proteostasis and a powerful cell-intrinsic host defense mechanism, protecting cells against pathogens by targeting them through a specific form of selective autophagy known as xenophagy. In this context, ubiquitination acts as a signal of recognition of the cargoes for autophagic receptors, which direct them towards autophagosomes for subsequent breakdown. Nevertheless, autophagy can carry out a dual role since numerous viruses including members of the Orthoherpesviridae family can either inhibit or exploit autophagy for its own benefit and to replicate within host cells. There is growing evidence that Herpes simplex virus type 1 (HSV-1), a highly prevalent human pathogen that infects epidermal keratinocytes and sensitive neurons, is capable of negatively modulating autophagy. Since the effects of HSV-1 infection on autophagic receptors have been poorly explored, this study aims to understand the consequences of HSV-1 productive infection on the levels of the major autophagic receptors involved in xenophagy, key proteins in the recruitment of intracellular pathogens into autophagosomes. We found that productive HSV-1 infection in human neuroglioma cells and keratinocytes causes a reduction in the total levels of Ub conjugates and decreases protein levels of autophagic receptors, including SQSTM1/p62, OPTN1, NBR1, and NDP52, a phenotype that is also accompanied by reduced levels of LC3-I and LC3-II, which interact directly with autophagic receptors. Mechanistically, we show these phenotypes are the result of xenophagy activation in the early stages of productive HSV-1 infection to limit virus replication, thereby reducing progeny HSV-1 yield. Additionally, we found that the removal of the tegument HSV-1 protein US11, a recognized viral factor that counteracts autophagy in host cells, enhances the clearance of autophagic receptors, with a significant reduction in the progeny HSV-1 yield. Moreover, the removal of US11 increases the ubiquitination of SQSTM1/p62, indicating that US11 slows down the autophagy turnover of autophagy receptors. Overall, our findings suggest that xenophagy is a potent host defense against HSV-1 replication and reveals the role of the autophagic receptors in the delivery of HSV-1 to clearance via xenophagy.

30 January 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
Hianara Aracelly BustamanteHianara Aracelly Bustamante
Hianara Aracelly Bustamante
KCKarina Cereceda
Karina Cereceda
AGAlexis Gonzalez
Alexis Gonzalez
GNGuillermo Eduardo Valenzuela Nieto
Guillermo Eduardo Valenzuela Nieto
YCYorka Cheuquemilla
Yorka Cheuquemilla
ARAlejandro Rojas
Alejandro Rojas
Ubiquitination regulates several biological processes. Here, we search for ubiquitin-related genes implicated in protein membrane trafficking performing a High-Content siRNA Screening including 1,187 genes of the human “ubiquitinome” using Amyloid Precursor Protein (APP) as a reporter. We identified the deubiquitinating enzyme PSMD14, a subunit of the 19S regulatory particle of the proteasome, specific for K63-Ub chains in cells, as a novel key regulator of Golgi-to-endoplasmic reticulum (ER) retrograde transport. Silencing or pharmacological inhibition of PSMD14 caused a robust and rapid inhibition of Golgi-to-ER retrograde transport which leads to a potent blockage of macroautophagy by a mechanism associated with the retention of Atg9A and Rab1A at the Golgi apparatus. Because pharmacological inhibition of the proteolytic core of the 20S proteasome did not recapitulate these effects, we concluded that PSMD14, and their K-63-Ub chains, act as a crucial regulator factor for macroautophagy by controlling Golgi-to-ER retrograde transport.

13 November 2025 in Pest Management Science
Verified
Journal Article
Closed access
AMAlejandro Madrid
Alejandro Madrid
GBGuillermo Bravo
Guillermo Bravo
DNDiyanira Castillo Novales
Diyanira Castillo Novales
VMValentina Navarrete Molina
Valentina Navarrete Molina
ASAldo Salinas
Aldo Salinas
IMIván Montenegro
Iván Montenegro